<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="patients associated with respiratory distress syndrome (ARDS) often necessitating respirator" exact="treatment" post="and associated with a high mortality [1â€&quot;3]. Epidemics in"/>
 <result pre="developed into a pandemic necessitating urgent worldwide co-operation. Until effective" exact="treatment" post="of COVID-19 including a useful vaccination against SARS-CoV-2 is"/>
 <result pre="injury [5]. Inhibitors of the reninâ€&quot;angiotensin system (RASi), cornerstones of" exact="treatment" post="of patients with hypertension and heart failure, have attracted"/>
 <result pre="levels, and may in this respect be helpful, chronic RASi" exact="treatment" post="may on the other hand also increase pulmonary ACE2-receptor"/>
 <result pre="higher SARS-CoV-2 viral load. As suggested from animal experiments, chronic" exact="treatment" post="with RASi can therefore, in theory, both increase and"/>
 <result pre="1 March and 1 April 2020, had remained admitted with" exact="infection" post="to hospital for at least 24â€Šh in two of"/>
 <result pre="was only 2.04 further days (SD 2.29; range 0â€&quot;10). Medical" exact="treatment" post="for chronic obstructive pulmonary disease, statins, antithrombotic drugs, and"/>
 <result pre="groups, while beta-blockers and spironolactone seem unevenly distributed with higher" exact="prevalence" post="among patients, who were admitted to the ICU or"/>
 <result pre="beta-blockers independently increased odds for ICU-admission or death, but RASi" exact="treatment" post="did not. TABLE 1 Characteristics of patients hospitalized for"/>
 <result pre="ICU or death Current consensus [4,6] recommends not changing RASi" exact="treatment" post="in patients with SARS-CoV-2 infection. Whereas we found other"/>
 <result pre="data do not suggest any significant influence from chronic RASi" exact="treatment" post="and hence our data bring some reassurance to the"/>
 <result pre="consensus of not changing RASi medication. Randomized studies on RASi" exact="treatment" post="intervention in patients at risk of COVID-19 should consider"/>
</results>
